PLZF is a negative regulator of retinoic acid receptor transcriptional activity.

Perrine J Martin, Marie-Hélène Delmotte, Pierre Formstecher, Philippe Lefebvre
{"title":"PLZF is a negative regulator of retinoic acid receptor transcriptional activity.","authors":"Perrine J Martin,&nbsp;Marie-Hélène Delmotte,&nbsp;Pierre Formstecher,&nbsp;Philippe Lefebvre","doi":"10.1186/1478-1336-1-6","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND: Retinoic acid receptors (RARs) are ligand-regulated transcription factors controlling cellular proliferation and differentiation. Receptor-interacting proteins such as corepressors and coactivators play a crucial role in specifying the overall transcriptional activity of the receptor in response to ligand treatment. Little is known however on how receptor activity is controlled by intermediary factors which interact with RARs in a ligand-independent manner. RESULTS: We have identified the promyelocytic leukemia zinc finger protein (PLZF), a transcriptional corepressor, to be a RAR-interacting protein using the yeast two-hybrid assay. We confirmed this interaction by GST-pull down assays and show that the PLZF N-terminal zinc finger domain is necessary and sufficient for PLZF to bind RAR. The RAR ligand binding domain displayed the highest affinity for PLZF, but corepressor and coactivator binding interfaces did not contribute to PLZF recruitment. The interaction was ligand-independent and correlated to a decreased transcriptional activity of the RXR-RAR heterodimer upon overexpression of PLZF. A similar transcriptional interference could be observed with the estrogen receptor alpha and the glucocorticoid receptor. We further show that PLZF is likely to act by preventing RXR-RAR heterodimerization, both in-vitro and in intact cells. CONCLUSION: Thus RAR and PLZF interact physically and functionally. Intriguingly, these two transcription factors play a determining role in hematopoiesis and regionalization of the hindbrain and may, upon chromosomal translocation, form fusion proteins. Our observations therefore define a novel mechanism by which RARs activity may be controlled.</p>","PeriodicalId":86148,"journal":{"name":"Nuclear receptor","volume":"1 1","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2003-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1478-1336-1-6","citationCount":"37","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear receptor","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1478-1336-1-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 37

Abstract

BACKGROUND: Retinoic acid receptors (RARs) are ligand-regulated transcription factors controlling cellular proliferation and differentiation. Receptor-interacting proteins such as corepressors and coactivators play a crucial role in specifying the overall transcriptional activity of the receptor in response to ligand treatment. Little is known however on how receptor activity is controlled by intermediary factors which interact with RARs in a ligand-independent manner. RESULTS: We have identified the promyelocytic leukemia zinc finger protein (PLZF), a transcriptional corepressor, to be a RAR-interacting protein using the yeast two-hybrid assay. We confirmed this interaction by GST-pull down assays and show that the PLZF N-terminal zinc finger domain is necessary and sufficient for PLZF to bind RAR. The RAR ligand binding domain displayed the highest affinity for PLZF, but corepressor and coactivator binding interfaces did not contribute to PLZF recruitment. The interaction was ligand-independent and correlated to a decreased transcriptional activity of the RXR-RAR heterodimer upon overexpression of PLZF. A similar transcriptional interference could be observed with the estrogen receptor alpha and the glucocorticoid receptor. We further show that PLZF is likely to act by preventing RXR-RAR heterodimerization, both in-vitro and in intact cells. CONCLUSION: Thus RAR and PLZF interact physically and functionally. Intriguingly, these two transcription factors play a determining role in hematopoiesis and regionalization of the hindbrain and may, upon chromosomal translocation, form fusion proteins. Our observations therefore define a novel mechanism by which RARs activity may be controlled.

Abstract Image

Abstract Image

Abstract Image

PLZF是维甲酸受体转录活性的负调控因子。
背景:视黄酸受体(RARs)是配体调控的转录因子,控制细胞增殖和分化。受体相互作用蛋白,如辅抑制因子和辅激活因子,在指定受体响应配体处理的整体转录活性方面起着至关重要的作用。然而,关于受体活性如何由与RARs以不依赖于配体的方式相互作用的中间因子控制,我们所知甚少。结果:我们利用酵母双杂交实验鉴定了早幼粒细胞白血病锌指蛋白(PLZF),一种转录辅抑制因子,是一种与rar相互作用的蛋白。我们通过GST-pull - down实验证实了这种相互作用,并表明PLZF n端锌指结构域是PLZF结合RAR的必要和充分条件。RAR配体结合域对PLZF的亲和力最高,但辅抑制因子和辅激活因子结合界面对PLZF的募集没有贡献。这种相互作用与配体无关,与PLZF过表达后RXR-RAR异源二聚体转录活性降低有关。雌激素受体α和糖皮质激素受体也存在类似的转录干扰。我们进一步表明,在体外和完整细胞中,PLZF可能通过阻止RXR-RAR异源二聚化起作用。结论:RAR与PLZF在生理和功能上相互作用。有趣的是,这两种转录因子在造血和后脑区域化中起决定性作用,并可能在染色体易位时形成融合蛋白。因此,我们的观察定义了一种控制RARs活性的新机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信